Zerodha > Trade @ ₹20 (Free Delivery)Know More
Free Account Opening + AMC Free Demat

Auro Impex IPO vs Remus Pharmaceuticals IPO

Comparison between Auro Impex IPO and Remus Pharmaceuticals IPO.

IPO Details

Auro Impex IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Remus Pharmaceuticals IPO is a SME Bookbuilding proposed to list at NSE SME.

 Auro Impex IPORemus Pharmaceuticals IPO
LogoAuro Impex IPO LogoRemus Pharmaceuticals IPO Logo
Issue CategorySMESME
Issue TypeIPOIPO
Process TypeBookbuildingBookbuilding
Listing AtNSE SMENSE SME
Lead ManagersAffinity Global Capital Market Pvt.Ltd.Beeline Capital Advisors Pvt.Ltd.
RegistrarCameo Corporate Services Ltd.MUFG Intime India Pvt.Ltd.
Market MakerRikhav Securities Ltd.Sunflower Broking Pvt.Ltd.
DRHPDRHP DRHP
RHPRHP RHP
Anchor InvestorAnchor Investor
IPO Allotment URLIPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Auro Impex IPO is up to ₹25.71 Cr whereas the issue size of the Remus Pharmaceuticals IPO is up to ₹45.29 Cr. The final issue price of Auro Impex IPO is ₹78.00 per share and of Remus Pharmaceuticals IPO is ₹1,229.00 per share.

 Auro Impex IPORemus Pharmaceuticals IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹74.00 per share₹1,150.00 per share
Issue Price (Upper)₹78.00 per share₹1,229.00 per share
Issue Price (Final)₹78.00 per share₹1,229.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)
Market Lot Size1600 shares100 shares
Fresh Issue Size27,45,600 shares3,68,500 shares
Fresh Issue Size (Amount)up to ₹21.42 Crup to ₹45.29 Cr
OFS Issue Size5,50,400 shares0 shares
OFS Issue Size (Amount)up to ₹4.29 Crup to ₹0.00 Cr
Issue Size Total32,96,000 shares3,68,500 shares
Issue Size Total (Amount)up to ₹25.71 Crup to ₹45.29 Cr

IPO Timetable

Auro Impex IPO opens on May 11, 2023, while Remus Pharmaceuticals IPO opens on May 17, 2023. The closing date of Auro Impex IPO and Remus Pharmaceuticals IPO is May 15, 2023, and May 19, 2023, respectively.

 Auro Impex IPORemus Pharmaceuticals IPO
Anchor Bid DateMay 16, 2023
Issue OpenMay 11, 2023May 17, 2023
Issue CloseMay 15, 2023May 19, 2023
Basis Of Allotment (Tentative)May 18, 2023May 24, 2023
Initiation of Refunds (Tentative)May 19, 2023May 25, 2023
Credit of Share (Tentative)May 22, 2023May 26, 2023
Listing date (Tentative)May 23, 2023May 29, 2023
Anchor Lockin End date 1Jun 23, 2023
Anchor Lockin End date 2Aug 22, 2023

Financials & KPIs

Auro Impex IPO P/E ratio is 12.07, as compared to Remus Pharmaceuticals IPO P/E ratio of 21.09.

 Auro Impex IPORemus Pharmaceuticals IPO
Financials
Auro Impex & Chemicals Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-202,841.423,760.9827.01322.62
31-Mar-213,360.597,372.7090.54413.16
31-Mar-226,219.5615,184.93230.031,155.041,077.703,679.97
31-Mar-238,228.0923,296.54599.921,754.96826.884,875.92
Amount in ₹ Lakhs
Remus Pharmaceuticals Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-20530.361,276.8981.16202.03201.0335.93
31-Mar-211,104.961,922.45102.58304.61303.6127.89
31-Mar-221,590.932,543.71338.57643.17543.1719.17
31-Dec-223,352.963,361.20643.901,712.071,603.57947.45
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue)99.9992.82
Promoter Shareholding (Post-Issue)68.37
P/E Ratio12.0721.09
Market Cap₹95.17 Cr.₹181.03 Cr.
ROE71.44%
ROCE69.99%
Debt/Equity2.770.03
EPS₹6.00₹33.86
RoNW19.92%52.64%

Shares Offered

In the Auro Impex IPO Retail Individual Investors (RII) are offered 18,46,400 shares while in Remus Pharmaceuticals IPO retail investors are offered 18,46,400 shares. Qualified Institutional Buyers (QIB) are offered 3,29,600 shares in Auro Impex IPO and 73,700 shares in Remus Pharmaceuticals IPO.

 Auro Impex IPORemus Pharmaceuticals IPO
Anchor Investor Reserveration1,10,500 shares
Market Maker Reserveration1,74,400 shares19,500 shares
QIB3,29,600 shares73,700 shares
NII11,20,000 shares55,300 shares
RII18,46,400 shares1,29,000 shares
Employee
Others
Total32,96,000 shares3,68,500 shares

Bids Received (Subscription)

Auro Impex IPO subscribed 66.94x in total, whereas Remus Pharmaceuticals IPO subscribed 57.21x.

 Auro Impex IPORemus Pharmaceuticals IPO
QIB (times)31.67x10.75x
NII (times)104.05x229.31x
Big NII (times)
Small NII (times)
RII (times)50.72x49.81x
Employee (times)
Other (times)
Total (times)66.94x57.21x